Keeping vaccines safe – New podcast on COVID-19 vaccine surveillance

Signal detection / 29 June 2021

Photo: iStock

UMC experts discuss how real-time vaccine surveillance works during a pandemic and the role of VigiBase in helping to ensure public safety.

With COVID-19 vaccinations rolling at full speed in many countries, there’s a lot of talk about vaccine safety monitoring. But what exactly does that mean and how should we be interpreting data on side effects? Uppsala Monitoring Centre’s Helena Sköld and Annette Rudolph walk us through the basics of vaccine pharmacovigilance.

Helena Sköld and Annette Rudolph. Photos: UMC

Helena Sköld and Annette Rudolph. Photos: UMC

Subscribe by visiting the Drug Safety Matters website or listen in right here:

You may also like

Unmasking data in the COVID-19 vaccine era – New podcast episode

What are the implications for signal detection when new approaches to reporting create greater data streams than have ever been present for older medicinal products?

Signal detection / 30 January 2023

Record growth pushes VigiBase past 28 million reports

After decades of slow but steady growth, VigiBase has recently entered a new phase of accelerating expansion, driven by a range of converging forces.

Signal detection / 16 September 2021

Vaccine surveillance systems explained – new podcast episode

Ever wondered how safety surveillance differs between vaccines and drugs? Find out in the latest episode of the Drug Safety Matters podcast.

Signal detection / 25 August 2022

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more